Lack of association between fluoroquinolone and aortic aneurysm or dissection
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Huh, Kyungmin | - |
dc.contributor.author | Kang, Minsun | - |
dc.contributor.author | Jung, Jaehun | - |
dc.date.accessioned | 2024-02-08T03:00:21Z | - |
dc.date.available | 2024-02-08T03:00:21Z | - |
dc.date.issued | 2023-11 | - |
dc.identifier.issn | 0195-668X | - |
dc.identifier.issn | 1522-9645 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/90329 | - |
dc.description.abstract | Background and Aims An increased risk of aortic aneurysm and aortic dissection (AA/AD) has been reported with fluoroquinolone (FQ) use. However, recent studies suggested confounding factors by indication. This study aimed to investigate the risk of AA/AD associated with FQ use.Methods This nationwide population-based study included adults aged >= 20 years who received a prescription of oral FQ or third-generation cephalosporins (3GC) during outpatient visits from 2005 to 2016. Data source was the National Health Insurance Service reimbursement database. The primary outcome was hospitalization or in-hospital death with a primary diagnosis of AA/AD. A self-controlled case series (SCCS) and Cox proportional hazards model were used. Self-controlled case series compared the incidence of the primary outcome in the risk period vs. the control periods.Results A total of 954 308 patients (777 109 with FQ and 177 199 with 3GC use) were included. The incidence rate ratios for AA/AD between the risk period and the pre-risk period were higher in the 3GC group [11.000; 95% confidence interval (CI) 1.420-85.200] compared to the FQ group (2.000; 95% CI 0.970-4.124). The overall incidence of AA/AD among the patients who received FQ and 3GC was 5.40 and 8.47 per 100 000 person-years. There was no significant difference in the risk between the two groups (adjusted hazard ratio 0.752; 95% CI 0.515-1.100) in the inverse probability of treatment-weighted Cox proportional hazards model. Subgroup and sensitivity analysis showed consistent results.Conclusions There was no significant difference in the risk of AA/AD in patients who were administered oral FQ compared to those administered 3GC. The study findings suggest that the use of FQ should not be deterred when clinically indicated. Structured Graphical Abstract FQ, fluoroquinolone; 3GC, 3rd generation cephalosporin; HR, hazard ratio; CI, confidence interval; IPTW, inverse probability of treatment weighting. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | OXFORD UNIV PRESS | - |
dc.title | Lack of association between fluoroquinolone and aortic aneurysm or dissection | - |
dc.type | Article | - |
dc.identifier.wosid | 001078553200001 | - |
dc.identifier.doi | 10.1093/eurheartj/ehad627 | - |
dc.identifier.bibliographicCitation | EUROPEAN HEART JOURNAL, v.44, no.42, pp 4476 - 4484 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85176508582 | - |
dc.citation.endPage | 4484 | - |
dc.citation.startPage | 4476 | - |
dc.citation.title | EUROPEAN HEART JOURNAL | - |
dc.citation.volume | 44 | - |
dc.citation.number | 42 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordAuthor | Fluoroquinolones | - |
dc.subject.keywordAuthor | Antibiotics | - |
dc.subject.keywordAuthor | Aortic aneurysm | - |
dc.subject.keywordAuthor | Aortic dissection | - |
dc.subject.keywordPlus | INFECTIOUS-DISEASES SOCIETY | - |
dc.subject.keywordPlus | CLINICAL-PRACTICE GUIDELINE | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | PNEUMONIA | - |
dc.subject.keywordPlus | ADULTS | - |
dc.subject.keywordPlus | CELLS | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.